ImmunityBio (IBRX) EBITDA Margin Growth (1y) (2015 - 2026)
ImmunityBio (IBRX) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 23,220.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,220.00 |
| Dec 31, 2025 | 75,001.00 |
| Sep 30, 2025 | 114,082.00 |
| Jun 30, 2025 | 921,763.00 |
| Mar 31, 2025 | 23.76 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 9.64 Mn |
| Jun 30, 2024 | 19.82 Mn |
| Mar 31, 2024 | -20.70 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 65.45 Mn |
| Dec 31, 2022 | -9.60 Mn |
| Sep 30, 2022 | 4.25 Mn |
| Jun 30, 2022 | -20.22 Mn |
| Mar 31, 2022 | -62.35 Mn |
| Dec 31, 2021 | 12.67 Mn |
| Sep 30, 2021 | -7.58 Mn |
| Jun 30, 2021 | -1.37 Mn |